“Estimating the Budget Impact of Innovative Pharmacological Treatments for Patients With Type 2 Diabetes Mellitus in Italy: The Case of Liraglutide (GLP-1). ”. Epidemiology, Biostatistics, and Public Health, vol. 12, no. 2, May 2022, https://doi.org/10.2427/11082.